Research programme: metastatic melanoma therapeutics and diagnostics - SolaranRxAlternative Names: SRX-1177
Latest Information Update: 08 Jan 2016
At a glance
- Originator University of New Mexico
- Class Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals
- Mechanism of Action Melanocortin type 1 receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Malignant melanoma